Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
LATEST POSTS
- 1
Israel kidnaps PIJ terrorist in covert op. in Hamas-controlled Gaza in pursuit of Ran Gvili - 2The Craft of Do-It-Yourself Home Stylistic layout: Change Your Space
- 3Climbing Mount Everest: An Individual Victory
- 4Central African Republic's president sworn in for a third term after disputed election
- 5US FDA investigates Takeda's blood disorder drug after pediatric death
- Indoor Drinking Fountains: Famous Home Advancements during the Pandemic
- The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- I'm an 83-year-old yoga instructor. I'm not your typical grandma — I still work to feel fulfilled and supplement my Social Security.
- Find the Excellence of Old style Expressive dance: Encountering the Effortlessness and Polish of Dance
- Comet Lemmon and Milky Way spotted over Hawaii | Space photo of the day for Dec. 12, 2025
- The year's first meteor shower and supermoon clash in January skies
- Extraordinary Snowboarding Objections All over the Planet
- A top Marine shares his secrets to keeping fit at 50
- New findings suggest atmosphere could exist on exoplanet TOI-561b
